January 16, 2026 · Form 4 insider transaction
MALCOLM JAN sold 50 shares of United Therapeutics Corporation at $460.98 per share, a transaction worth $23.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025.